Reach Us +441730450007
Editor - Milt Teitler | Albany Medical College | 16355
ISSN: 2329-6895

Journal of Neurological Disorders
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Milt Teitler

Milt Teitler
Milt Teitler, PhD
Center for Neuropharmacology & Neuroscience
Albany Medical College
Albany Medical College


Professor Milt Teitler has published ~160 peer-reviewed papers, chapters, and reviews and one book on the molecular pharmacology of receptors. Prof Teitler has been working with GPCRs since 1976, his first publication appearing early in 1977. His laboratory was the first to reveal the GTP-sensitive high and low affinity states of the 5-HT2A receptor, published several papers revealing that the initial interaction of LSD-like hallucinogens with the 5-HT2A receptor leads to their psychotomimetic effects, published the most detailed autoradiographical mapping of the r5-HT2A receptor and demonstrated that many antipsychotics have inverse agonist properties. The h5-HT1E receptor was discovered in his laboratory using human tissue and he recently published investigations of the function and distribution of this receptor in guinea pig brain. His laboratory recently demonstrated the novel non-competitive properties of antipsychotic drugs binding to serotonin receptors. These studies indicate GPCRs may function as homodimers and has major implications for drug development.

Research Interest

Molecular pharmacology of serotonin and dopamine G-protein coupled receptors.
Mechanisms of existing drugs and development of novel drugs for treating schizophrenia
Depression and other neurological and psychiatric conditions.



Global Speakers in the subject

Global Experts in the subject

Relevant Topics